Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO.1 TO FORM S-1 - Revance Therapeutics, Inc. | d736274ds1a.htm |
| EX-5.1 - EX-5.1 - Revance Therapeutics, Inc. | d736274dex51.htm |
| EX-1.1 - EX-1.1 - Revance Therapeutics, Inc. | d736274dex11.htm |
| EX-10.32 - EX-10.32 - Revance Therapeutics, Inc. | d736274dex1032.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Amendment No. 1 to Form S-1 of our report dated March 28, 2014 relating to the financial statements, which appears in Revance Therapeutics Inc.’s Annual Report on Form 10-K for the year ended December 31, 2013. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
San Jose, California
June 16, 2014